Racial differences in association of serum calcium with mortality and incident cardio- and cerebrovascular events

Jun Ling Lu, M. Molnár, Jennie Z. Ma, Lekha K. George, Keiichi Sumida, Kamyar Kalantar-Zadeh, Csaba P. Kovesdy

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Context: Abnormalities in calcium metabolism may potentially contribute to the development of vascular disease. Calcium metabolism may be different in African American (AA) vs white individuals, but the effect of race on the association of serum calcium with clinical outcomes remains unclear. Objective: This study sought to examine race-specific associations of serum calcium levels with mortality and with major incident cardiovascular events. Design and Setting: This was a historical cohort study in the U.S. Department of Veterans Affairs health care facilities. Participants: Participants included veterans (n = 1 967 622) with estimated glomerular filtration rate ≥ 60 mL/min/1.73 m2. Main Outcome Measures: The association between serum calcium levels with all-cause mortality, incident coronary heart disease (CHD), and ischemic stroke incidence was examined in multivariable adjusted Cox proportional hazards models, including an interaction term for calcium and race. Results: The association of calcium with all-cause mortality was U-shaped in both AA and white patients, but race modified the association of calcium with all-cause mortality. Compared with white patients,AApatients experienced lower risk of mortalitywhencalciumwas<8.8 mg/dL, with a statistically significant interaction (P < .001). Conversely, AA vs white race was associated with higher mortality when calcium was < 8.8 mg/dL. Calcium showed no significant association with ischemic stroke or CHD in both races; and race did not modify these associations (P =.37 and 0.11, respectively for interaction term). Conclusions: Race modified the U-shaped association between calcium and all-cause mortality. Serum calcium is not associated with incident stroke or CHD in either AA or white patients. The race-specific difference in the association of calcium levels with mortality warrants further examination.

Original languageEnglish
Pages (from-to)4851-4859
Number of pages9
JournalJournal of Clinical Endocrinology and Metabolism
Volume101
Issue number12
DOIs
Publication statusPublished - Dec 1 2016

Fingerprint

Calcium
Mortality
Serum
African Americans
Coronary Disease
Stroke
Metabolism
Veterans Health
Health Facilities
Veterans
Glomerular Filtration Rate
Vascular Diseases
Health care
Proportional Hazards Models
Myocardial Ischemia
Hazards
Cohort Studies
Outcome Assessment (Health Care)
Delivery of Health Care
Incidence

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Racial differences in association of serum calcium with mortality and incident cardio- and cerebrovascular events. / Lu, Jun Ling; Molnár, M.; Ma, Jennie Z.; George, Lekha K.; Sumida, Keiichi; Kalantar-Zadeh, Kamyar; Kovesdy, Csaba P.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 101, No. 12, 01.12.2016, p. 4851-4859.

Research output: Contribution to journalArticle

Lu, Jun Ling ; Molnár, M. ; Ma, Jennie Z. ; George, Lekha K. ; Sumida, Keiichi ; Kalantar-Zadeh, Kamyar ; Kovesdy, Csaba P. / Racial differences in association of serum calcium with mortality and incident cardio- and cerebrovascular events. In: Journal of Clinical Endocrinology and Metabolism. 2016 ; Vol. 101, No. 12. pp. 4851-4859.
@article{48fd76c9302a4016aa05b7aa9a85233a,
title = "Racial differences in association of serum calcium with mortality and incident cardio- and cerebrovascular events",
abstract = "Context: Abnormalities in calcium metabolism may potentially contribute to the development of vascular disease. Calcium metabolism may be different in African American (AA) vs white individuals, but the effect of race on the association of serum calcium with clinical outcomes remains unclear. Objective: This study sought to examine race-specific associations of serum calcium levels with mortality and with major incident cardiovascular events. Design and Setting: This was a historical cohort study in the U.S. Department of Veterans Affairs health care facilities. Participants: Participants included veterans (n = 1 967 622) with estimated glomerular filtration rate ≥ 60 mL/min/1.73 m2. Main Outcome Measures: The association between serum calcium levels with all-cause mortality, incident coronary heart disease (CHD), and ischemic stroke incidence was examined in multivariable adjusted Cox proportional hazards models, including an interaction term for calcium and race. Results: The association of calcium with all-cause mortality was U-shaped in both AA and white patients, but race modified the association of calcium with all-cause mortality. Compared with white patients,AApatients experienced lower risk of mortalitywhencalciumwas<8.8 mg/dL, with a statistically significant interaction (P < .001). Conversely, AA vs white race was associated with higher mortality when calcium was < 8.8 mg/dL. Calcium showed no significant association with ischemic stroke or CHD in both races; and race did not modify these associations (P =.37 and 0.11, respectively for interaction term). Conclusions: Race modified the U-shaped association between calcium and all-cause mortality. Serum calcium is not associated with incident stroke or CHD in either AA or white patients. The race-specific difference in the association of calcium levels with mortality warrants further examination.",
author = "Lu, {Jun Ling} and M. Moln{\'a}r and Ma, {Jennie Z.} and George, {Lekha K.} and Keiichi Sumida and Kamyar Kalantar-Zadeh and Kovesdy, {Csaba P.}",
year = "2016",
month = "12",
day = "1",
doi = "10.1210/jc.2016-1802",
language = "English",
volume = "101",
pages = "4851--4859",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "12",

}

TY - JOUR

T1 - Racial differences in association of serum calcium with mortality and incident cardio- and cerebrovascular events

AU - Lu, Jun Ling

AU - Molnár, M.

AU - Ma, Jennie Z.

AU - George, Lekha K.

AU - Sumida, Keiichi

AU - Kalantar-Zadeh, Kamyar

AU - Kovesdy, Csaba P.

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Context: Abnormalities in calcium metabolism may potentially contribute to the development of vascular disease. Calcium metabolism may be different in African American (AA) vs white individuals, but the effect of race on the association of serum calcium with clinical outcomes remains unclear. Objective: This study sought to examine race-specific associations of serum calcium levels with mortality and with major incident cardiovascular events. Design and Setting: This was a historical cohort study in the U.S. Department of Veterans Affairs health care facilities. Participants: Participants included veterans (n = 1 967 622) with estimated glomerular filtration rate ≥ 60 mL/min/1.73 m2. Main Outcome Measures: The association between serum calcium levels with all-cause mortality, incident coronary heart disease (CHD), and ischemic stroke incidence was examined in multivariable adjusted Cox proportional hazards models, including an interaction term for calcium and race. Results: The association of calcium with all-cause mortality was U-shaped in both AA and white patients, but race modified the association of calcium with all-cause mortality. Compared with white patients,AApatients experienced lower risk of mortalitywhencalciumwas<8.8 mg/dL, with a statistically significant interaction (P < .001). Conversely, AA vs white race was associated with higher mortality when calcium was < 8.8 mg/dL. Calcium showed no significant association with ischemic stroke or CHD in both races; and race did not modify these associations (P =.37 and 0.11, respectively for interaction term). Conclusions: Race modified the U-shaped association between calcium and all-cause mortality. Serum calcium is not associated with incident stroke or CHD in either AA or white patients. The race-specific difference in the association of calcium levels with mortality warrants further examination.

AB - Context: Abnormalities in calcium metabolism may potentially contribute to the development of vascular disease. Calcium metabolism may be different in African American (AA) vs white individuals, but the effect of race on the association of serum calcium with clinical outcomes remains unclear. Objective: This study sought to examine race-specific associations of serum calcium levels with mortality and with major incident cardiovascular events. Design and Setting: This was a historical cohort study in the U.S. Department of Veterans Affairs health care facilities. Participants: Participants included veterans (n = 1 967 622) with estimated glomerular filtration rate ≥ 60 mL/min/1.73 m2. Main Outcome Measures: The association between serum calcium levels with all-cause mortality, incident coronary heart disease (CHD), and ischemic stroke incidence was examined in multivariable adjusted Cox proportional hazards models, including an interaction term for calcium and race. Results: The association of calcium with all-cause mortality was U-shaped in both AA and white patients, but race modified the association of calcium with all-cause mortality. Compared with white patients,AApatients experienced lower risk of mortalitywhencalciumwas<8.8 mg/dL, with a statistically significant interaction (P < .001). Conversely, AA vs white race was associated with higher mortality when calcium was < 8.8 mg/dL. Calcium showed no significant association with ischemic stroke or CHD in both races; and race did not modify these associations (P =.37 and 0.11, respectively for interaction term). Conclusions: Race modified the U-shaped association between calcium and all-cause mortality. Serum calcium is not associated with incident stroke or CHD in either AA or white patients. The race-specific difference in the association of calcium levels with mortality warrants further examination.

UR - http://www.scopus.com/inward/record.url?scp=85003486129&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85003486129&partnerID=8YFLogxK

U2 - 10.1210/jc.2016-1802

DO - 10.1210/jc.2016-1802

M3 - Article

VL - 101

SP - 4851

EP - 4859

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 12

ER -